158 related articles for article (PubMed ID: 25730680)
21. Management of radiation maculopathy.
Singh AD; Pabon S; Aronow ME
Ophthalmic Res; 2012; 48 Suppl 1():26-31. PubMed ID: 22907147
[TBL] [Abstract][Full Text] [Related]
22. Bevacizumab in vitreous haemorrhage secondary to radiation retinopathy.
Montero JA; Yanez-Castro G; Sanchis-Merino ME; Ruiz-Moreno JM
BMJ Case Rep; 2014 Feb; 2014():. PubMed ID: 24510700
[TBL] [Abstract][Full Text] [Related]
23. Radiation maculopathy treated with intravitreal bevacizumab.
Sánchez-Vicente JL; Muñoz-Morales A; Galván-Carrasco MP; Castilla-Lázpita A; Vital-Berral C; Alfaro-Juárez A; Rueda-Rueda T
Arch Soc Esp Oftalmol; 2017 Jun; 92(6):283-286. PubMed ID: 27894518
[TBL] [Abstract][Full Text] [Related]
24. INTRAVITREAL DEXAMETHASONE IMPLANT FOR RADIATION MACULOPATHY SECONDARY TO PLAQUE BRACHYTHERAPY IN CHOROIDAL MELANOMA.
Caminal JM; Flores-Moreno I; Arias L; Gutiérrez C; Piulats JM; Català J; Rubio MJ; Cobos E; García P; Pera J; Giralt J; Arruga J
Retina; 2015 Sep; 35(9):1890-7. PubMed ID: 26035401
[TBL] [Abstract][Full Text] [Related]
25. Animal models of radiation retinopathy - From teletherapy to brachytherapy.
Ramos MS; Echegaray JJ; Kuhn-Asif S; Wilkinson A; Yuan A; Singh AD; Browne AW
Exp Eye Res; 2019 Apr; 181():240-251. PubMed ID: 30716328
[TBL] [Abstract][Full Text] [Related]
26. Intravitreal triamcinolone versus intravitreal bevacizumab in the treatment of exudative retinal detachment secondary to posterior uveal melanoma.
Parrozzani R; Pilotto E; Dario A; Miglionico G; Midena E
Am J Ophthalmol; 2013 Jan; 155(1):127-133.e2. PubMed ID: 22995029
[TBL] [Abstract][Full Text] [Related]
27. Anti-VEGF bevacizumab (Avastin) for radiation optic neuropathy.
Finger PT
Am J Ophthalmol; 2007 Feb; 143(2):335-8. PubMed ID: 17258524
[TBL] [Abstract][Full Text] [Related]
28. Bevacizumab therapy for tamoxifen-induced crystalline retinopathy and severe cystoid macular edema.
Rahimy E; Sarraf D
Arch Ophthalmol; 2012 Jul; 130(7):931-2. PubMed ID: 22776935
[No Abstract] [Full Text] [Related]
29. Intravitreal pegaptanib sodium (Macugen) for radiation retinopathy following episcleral plaque radiotherapy.
Querques G; Prascina F; Iaculli C; Delle Noci N
Acta Ophthalmol; 2008 Sep; 86(6):700-1. PubMed ID: 18705681
[No Abstract] [Full Text] [Related]
30. Best practices for treatment of retinal vein occlusion.
Hahn P; Fekrat S
Curr Opin Ophthalmol; 2012 May; 23(3):175-81. PubMed ID: 22450223
[TBL] [Abstract][Full Text] [Related]
31. Intravitreal bevacizumab in a patient with a macular star in malignant hypertension.
Zucchiatti I; Iacono P; Battaglia Parodi M; Cascavilla ML; Kontadakis DS; Bandello F
Eur J Ophthalmol; 2011; 21(3):336-9. PubMed ID: 20954147
[TBL] [Abstract][Full Text] [Related]
32. Epimacular Brachytherapy for Previously Treated Neovascular Age-Related Macular Degeneration (MERLOT): A Phase 3 Randomized Controlled Trial.
Jackson TL; Desai R; Simpson A; Neffendorf JE; Petrarca R; Smith K; Wittes J; Lewis C; Membrey L; Haynes R; Costen M; Steel DH; Muldrew A; Chakravarthy U;
Ophthalmology; 2016 Jun; 123(6):1287-96. PubMed ID: 27086023
[TBL] [Abstract][Full Text] [Related]
33. Combined bevacizumab and triamcinolone acetonide injections for macular edema in a patient with astrocytic hamartomas and tuberous sclerosis.
Lonngi M; Gold AS; Murray TG
Ophthalmic Surg Lasers Imaging Retina; 2013; 44(1):85-90. PubMed ID: 23410814
[TBL] [Abstract][Full Text] [Related]
34. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A
Retina; 2006; 26(9):999-1005. PubMed ID: 17151486
[TBL] [Abstract][Full Text] [Related]
35. Safety testing of epimacular brachytherapy with microperimetry and indocyanine green angiography: 12-month results.
Petrarca R; Richardson M; Douiri A; Nau J; McHugh D; Stangos AN; Jackson TL
Retina; 2013 Jun; 33(6):1232-40. PubMed ID: 23508075
[TBL] [Abstract][Full Text] [Related]
36. Preventing radiation retinopathy with hyperfractionation.
Monroe AT; Bhandare N; Morris CG; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):856-64. PubMed ID: 15708266
[TBL] [Abstract][Full Text] [Related]
37. Therapies for macular edema associated with central retinal vein occlusion: a report by the American Academy of Ophthalmology.
Yeh S; Kim SJ; Ho AC; Schoenberger SD; Bakri SJ; Ehlers JP; Thorne JE
Ophthalmology; 2015 Apr; 122(4):769-78. PubMed ID: 25576994
[TBL] [Abstract][Full Text] [Related]
38. Three-year safety and visual acuity results of epimacular 90 strontium/90 yttrium brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration.
Avila MP; Farah ME; Santos A; Carla L; Fuji G; Rossi J; Nau J
Retina; 2012 Jan; 32(1):10-8. PubMed ID: 21817963
[TBL] [Abstract][Full Text] [Related]
39. Diabetic macular edema.
Lang GE
Ophthalmologica; 2012; 227 Suppl 1():21-9. PubMed ID: 22517122
[TBL] [Abstract][Full Text] [Related]
40. Combined intravitreal bevacizumab injection and zone I sparing laser photocoagulation in patients with zone I retinopathy of prematurity.
Kim J; Kim SJ; Chang YS; Park WS
Retina; 2014 Jan; 34(1):77-82. PubMed ID: 23807184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
